Saturday, January 2, 2021

Portfolio update - 2020 October/November/December

My top (>2%) positions in no particular order: BRKB, FB, PSHZF, AAPL, EXXRF, GOOG,
In:
Out:
 
Fixed income: 9%
Cash: 13%

Sectors (kinda): Insurance (BRK): 12%, Malone/media: 1%, Banks/financials: 7%, Stock funds: 10%, Cars: 0%, Oil: 0%, Medical/pharma: 1%, Tech: 30%, Various owner-operators (not included in other categories): 5%

New positions: TTWO, IWF, INTC, MACE, MG, DFAU, DFAE, DFAI, SCPPF, CURN, MSPAF, MELI, RILY, BABA, YELP, XP
Positions increased: INNPRD, TRTNPRC, CBOE, ADSK, ANGI, GOOG, STNE, VMW, CHEK, FB
Positions reduced: DFS, EXPE, BKNG, NTES, JPM, AAPL, OTCM, AYRWF
Positions eliminated: VVNTWS, YY
Flip-flop: IAC, PSTH, INNPRE, CVS

I should post more often. Since this time covered 2.5 months, I have bought and sold a lot. 

On fixed income side I traded INNPRE as the price fluctuated. I added INNPRD and TRTNPRC.

I bought a bunch of IAC and ANGI at lower prices and then sold a bit of IAC as the price ran up on Vimeo spinoff news.

In tech space, I have initiated positions in TTWO (OK price), INTC (cheap if the company manages to not decline), MSPAF (tracking position), MELI (expensive but could grow into the valuation), BABA (cheap if one can trust financials and if Chinese regulators don't hit it very hard), SCPPF (tracking position), YELP (cheap if the company can perform - which it could not for last many years - tracking position). I added to ADSK (wide moat, no longer cheap), VMW (cheap), FB (still OK price), GOOG (still somewhat OK price). I sold some AAPL based on price although it is possibly a mistake. Also reduced EXPE and BKNG on run-up and forward valuation. These could be a mistake if travel recovers faster than expected and more than expected. Reduced some NTES.

I sold YY position after they reported selling their China business to Baidu. There was a short-seller report on YY that raised some legitimate issues though the accusation of wholesale fraud is not totally convincing. 

I bought some "value" stock positions: MG, MACE (tracking position), CURN.

In the financials space, I have bought RILY (possibly cheap, depending on future results), XP (expensive), added to CBOE (low conviction), STNE (very expensive now). I sold some DFS on run-up,  JPM on uncertain future, OTCM on price.

I am still undecided about CVS. I have added some and then sold most. Reduced some AYRWF on run-up.

In SPAC space, I traded PSTH as price fluctuated, selling below the recent highs though. I sold all VVNTWS and FSRWS. I bought and sold a long list of SPAC warrants that I won't list completely. It includes IPOBWS, IPOCWS, THCBW, CFIIW, NGAWS, APXTW, QSWS, LGVWWS, LAZRW, INAQW, STPKWS, BFTWS, GSAHWS, HTOOW, GIKWS, DMWS, TPGYWS, CGROW, FIIIW, SKLZWS, FSRVW, CLAWS. It has been a part of ongoing experiment in speculating in SPAC space (pun intended).

I bought some tracking positions for monitoring in ETFs: IWF and new Dimensional Funds ETFs: DFAU, DFAE, DFAI.

My 2020 returns were in 24-25% range outperforming SP500 for the first time in 9 years. One account concentrated on growth stocks produced 82% return. Maybe that's an indication of a bubble or a top. We'll see.